Acromegaly and Pregnancy: A Systematic Review Protocol

Main Article Content

Diego Barata Bandeira
Thaina Oliveira Felicio Olivatti
Fernanda Bolfi
Cesar Luiz Boguszewski
Vania dos Santos Nunes- Nogueira

Abstract

Introduction: Although the association between acromegaly and pregnancy has been studied, recent evidence synthesis is lacking.

Objective: To evaluate the association between acromegaly and pregnancy in terms of disease control and newborn/maternal outcomes.

Methods: We will perform a systematic review according to Joanna Briggs Institute methodology for systematic reviews of etiology and risk. We will include studies with pregnant women, over 18 years old, diagnosed with acromegaly before or during the first trimester of pregnancy. Studies with pregnancy before acromegaly diagnosis will be excluded. We will consider cohort and case-control studies, and case series (at least 3 participants). Maternal primary outcomes will be acromegaly control, preterm birth, presence of diabetes, hypertension and/or eclampsia, and frequency of abortion. Newborn primary outcomes will be perinatal mortality and low birthweight. General and adaptive search strategies have been created for the Embase, Medline, LILACS, and CENTRAL databases. Two independent reviewers will assess eligibility of the studies, extract data, and evaluate their risk of bias. For dichotomous data, effect estimates will be calculated using relative risk with 95% confidence intervals (CIs). Continuous data will be expressed as means and standard deviation (SD) for each study, and the mean difference will be calculated with respective 95% CIs. For non-controlled studies, maternal outcomes will be compared pre- and postpartum, and for abortion frequency and newborn outcomes, we will perform proportional meta-analysis. Conclusion: We hope that the results of this review can help the management of pregnant women with acromegaly.

Keywords:
Acromegaly, pituitary neoplasms, pregnancy.

Article Details

How to Cite
Bandeira, D. B., Olivatti, T. O. F., Bolfi, F., Boguszewski, C. L., & Nogueira, V. dos S. N.-. (2020). Acromegaly and Pregnancy: A Systematic Review Protocol. Asian Journal of Advanced Research and Reports, 14(4), 12-18. https://doi.org/10.9734/ajarr/2020/v14i430338
Section
Study Protocol

References

Chanson P, Vialon M, Caron P. An update on clinical care for pregnant women with acromegaly. Expert Rev Endocrinol Metab. 2019;14(2):85-96.

Goluboff LG, Ezrin C. Effect of pregnancy on the somatotroph and the prolactin cell of the human adenohypophysis. J Clin Endocrinol Metab. 1969;29(12):1533-8.

Muhammad A, Neggers SJ, van der Lely AJ. Pregnancy and acromegaly. Pituitary. 2017;20(1):179-84.

O'Herlihy C. Pregnancy in an acromegalic after bromocriptine therapy. Ir J Med Sci. 1980;149(7):281-2.

Montini M, Pagani G, Gianola D, Pagani MD, Piolini R, Camboni MG. Acromegaly and primary amenorrhea: ovulation and pregnancy induced by SMS 201-995 and bromocriptine. J Endocrinol Invest. 1990;13(2):193.

Hannon AM, O'Shea T, Thompson CA, Hannon MJ, Dineen R, Khattak A, et al. Pregnancy in acromegaly is safe and is associated with improvements in IGF-1 concentrations. Eur J Endocrinol. 2019;180(4):K21-K9.

Dias M, Boguszewski C, Gadelha M, Kasuki L, Musolino N, Vieira JG, et al. Acromegaly and pregnancy: a prospective study. Eur J Endocrinol. 2014;170(2):301-10.

Jallad RS, Shimon I, Fraenkel M, Medvedovsky V, Akirov A, Duarte FH, et al. Outcome of pregnancies in a large cohort of women with acromegaly. Clin Endocrinol (Oxf). 2018;88(6):896-907.

Katznelson L, Laws ER, Jr., Melmed S, Molitch ME, Murad MH, Utz A, et al. Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(11):3933-51.

Abucham J, Bronstein MD, Dias ML. Management of endocrine disease: Acromegaly and pregnancy: a contemporary review. Eur J Endocrinol. 2017;177(1):R1-R12.

Sant' Anna BG, Musolino NRC, Gadelha MR, Marques C, Castro M, Elias PCL, et al. A Brazilian multicentre study evaluating pregnancies induced by cabergoline in patients harboring prolactinomas. Pituitary. 2020;23(2):120-8.

Cheng S, Grasso L, Martinez-Orozco JA, Al-Agha R, Pivonello R, Colao A, et al. Pregnancy in acromegaly: Experience from two referral centers and systematic review of the literature. Clinical Endocrinology. 2012;76(2):264-71.

Karaca Z, Yarman S, Ozbas I, Kadioglu P, Akturk M, Kilicli F, et al. How does pregnancy affect the patients with pituitary adenomas: a study on 113 pregnancies from Turkey. J Endocrinol Invest. 2018;41(1):129-41.

Moola S MZ, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z (Editors). Joanna Briggs Institute Reviewer's Manual: The Joanna Briggs Institute; 2017. Available:https://reviewersmanual.joannabriggs.org/

Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ (Clinical research ed). 2015;350:g7647.

Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.

Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.

Alonso-Coello P, Oxman AD, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines. BMJ (Clinical research ed). 2016;353: i2089.